¼¼°èÀÇ ÇコÄÉ¾î ºÎÁ¤ ºÐ¼® ½ÃÀå
Healthcare Fraud Analytics
»óǰÄÚµå : 1330991
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2023³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 89 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,260,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,780,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÇコÄÉ¾î ºÎÁ¤ ºÐ¼® ½ÃÀåÀº 2030³â±îÁö 159¾ï ´Þ·¯¿¡ µµ´Þ

COVID-19 ÈÄÀÇ º¯È­ÇÑ ºñÁî´Ï½º ȯ°æ¿¡¼­ 2022³â¿¡ 30¾ï ´Þ·¯·Î ÃßÁ¤µÈ ¼¼°èÀÇ ÇコÄÉ¾î ºÎÁ¤ ºÐ¼® ½ÃÀåÀº 2030³â±îÁö 159¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2022-2030³â¿¡ 22.9%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ±â¼ú ºÐ¼®Àº CAGR 22.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 66¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇöÀç ÁøÇàÁßÀÎ ÆÒµ¥¹Í ÈÄ È¸º¹À» °í·ÁÇÏ¿© ¿¹Ãø ºÐ¼® ºÎ¹®ÀÇ ¼ºÀåÀº ÇâÈÄ 8³â°£ CAGRÀ» 19.6%·Î ¼öÁ¤Çß½À´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 9¾ï 1,170¸¸ ´Þ·¯, Áß±¹Àº CAGR 22.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ÇコÄÉ¾î ºÎÁ¤ ºÐ¼® ½ÃÀåÀº 2022³â¿¡´Â 9¾ï 1,170¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2022-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 22.1%·Î ÃßÀÌÇϸç, 2030³â±îÁö 27¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, 2022-2030³â¿¡ °¢°¢ 20%¿Í 18.5%ÀÇ ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Healthcare Fraud Analytics Market to Reach $15.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Healthcare Fraud Analytics estimated at US$3 Billion in the year 2022, is projected to reach a revised size of US$15.9 Billion by 2030, growing at aCAGR of 22.9% over the period 2022-2030. Descriptive Analytics, one of the segments analyzed in the report, is projected to record 22.5% CAGR and reach US$6.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Predictive Analytics segment is readjusted to a revised 19.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $911.7 Million, While China is Forecast to Grow at 22.1% CAGR

The Healthcare Fraud Analytics market in the U.S. is estimated at US$911.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 22.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 20% and 18.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14% CAGR.

Select Competitors (Total 33 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â